Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Impaired sleep-associated modulation of post-exercise corticomotor depression in multiple sclerosis.
Validity of Maximal Exercise Testing in Patients With Low to Moderate Multiple Sclerosis.
Glial cells suppress postencephalitic CD8(+) T lymphocytes through PD-L1.
HIV and lower risk of multiple sclerosis: beginning to unravel a mystery using a record-linked database study.
IL-17 and related cytokines involved in the pathology and immunotherapy of multiple sclerosis: Current and future developments.
Intestinal barrier dysfunction develops at the onset of experimental autoimmune encephalomyelitis, and can be induced by adoptive transfer of auto-reactive T cells.
Risk stratification and mitigation in multiple sclerosis.
PET imaging of focal demyelination and remyelination in a rat model of multiple sclerosis: comparison of [(11)C]MeDAS, [ (11)C]CIC and [ (11)C]PIB.
Aquaporin-4 autoimmunity in a child without optic neuritis and myelitis.
Predictions for the future of kallikrein-related peptidases in molecular diagnostics.
The multiple sclerosis self-management scale: clinicometric testing.
The Olig family affects central nervous system development and disease.
Detection of B-cell populations with monotypic light chain expression in cerebrospinal fluid specimens from patients with multiple sclerosis by polychromatic flow cytometry.
Evolution of longitudinally extensive transverse myelitis in an aquaporin-4 IgG-positive patient.
Epilepsy surgery outcome in temporal lobe cavernoma and multiple sclerosis.
Elevated Expression of Fractalkine (CX3CL1) and Fractalkine Receptor (CX3CR1) in the Dorsal Root Ganglia and Spinal Cord in Experimental Autoimmune Encephalomyelitis: Implications in Multiple Sclerosis-Induced Neuropathic Pain.
Eliminating Encephalitogenic T Cells without Undermining Protective Immunity.
Autoimmune Comorbidities Are Associated with Brain Injury in Multiple Sclerosis.
Intractable pruritus in neuromyelitis optica.
Cdon, a cell surface protein, mediates oligodendrocyte differentiation and myelination.
How does fingolimod (gilenya(®)) fit in the treatment algorithm for highly active relapsing-remitting multiple sclerosis?
Epidemiology of environmental exposures and human autoimmune diseases: Findings from a National Institute of Environmental Health Sciences Expert Panel Workshop.
Postural control strategy during standing is altered in patients with multiple sclerosis.
Visual Evoked Potential Recording in a Rat Model of Experimental Optic Nerve Demyelination.
Update in vitamin D and multiple sclerosis.

Pages